Core A - Administrative Core
核心 A - 行政核心
基本信息
- 批准号:10239106
- 负责人:
- 金额:$ 17.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-05-15 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:Autoimmune DiseasesAutoimmunityBlocking AntibodiesBusinessesCancer CenterChronicCollaborationsCommunicationCommunitiesConflict (Psychology)CritiquesDataData AnalysesData SetDevicesDiseaseEnsureEventGenetic TranscriptionImageImmunityImmunologyInternetLeadLettersLocationMaintenanceMalignant NeoplasmsManuscriptsMediatingMonitorMusOnline SystemsParticipantPlasmidsProcessProductivityProgress ReportsProtocols documentationPubMedReagentRegulationResearch PersonnelResolutionResource SharingResourcesRoleSecureShipsSiteSlideSourceSystemTeleconferencesTrainingTraining and EducationTumor ImmunityUniversitiesVirus DiseasesWorkantiviral immunitycell typecloud storageconflict resolutiondata sharingfallsmedical schoolsmeetingsmutant mouse modelorganizational structureperformance sitepreventprogrammed cell death protein 1programsreceptorresponsesymposiumsynergismtherapeutic targettherapeutically effectivetranscriptomicstumor
项目摘要
CORE SUMMARY
The Administrative Core (Core A) is an essential core that will coordinate and provide appropriate
administrative support for all three projects and the other three cores in this PPG. The Core will provide
administrative support for the PI of this Core and the PPG (Dr. Dario Vignali) and will be located in Department
of Immunology at the University of Pittsburgh School of Medicine, Pittsburgh, USA.
In the first ~4 years of this program, Core A established a centralized and transparent organizational structure
to coordinate all scientific aspects of the PPG and resolve any conflicts or issues. We have increased the role of
the Core to promote training, education and collaboration among trainees. This Core will pursue two aims:
AIM 1: To provide collaborative and educational support for the program. Core A will continue to support
and promote collaborative and educational efforts by performing the following four key tasks. (1) Maintain IR-
PPG Box account. (2) Organize monthly meetings. (3) Promote education and training. (4) Coordinate annual
PPG retreat and ESAG.
AIM 2: To provide administrative support for the program. Administrative support and coordination will be
provided through seven key tasks. (1) Monitor progress on Projects and use of Cores. (2) Prepare non-
competitive renewal applications/progress reports. (3) Provide budgetary management and fiscal, regulatory,
and compliance oversight. (4) Coordinate resource sharing. (5) Authentication of key resources. (6) Verification
of manuscript submission to PubMed Central. (7) Conflict resolution.
PPG Interactions: Core A will work extensively with Projects 1, 2, and 3 to provide administrative and
organizational support, monitoring progress, and hosting data and presentations. The Core will also help
coordinate Cores B, C, and D by providing a platform for data sharing, monitoring usage and productivity, and
managing budgetary responsibilities. Lastly, it will organize meetings and retreats.
核心摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dario AA Vignali其他文献
The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
- DOI:
10.1186/2051-1426-3-s2-p216 - 发表时间:
2015-11-04 - 期刊:
- 影响因子:10.600
- 作者:
Lawrence P Andrews;Andrea L Szymczak-Workman;Creg J Workman;Dario AA Vignali - 通讯作者:
Dario AA Vignali
Remodulation of the tumor microenvironment by regulatory T cells
- DOI:
10.1186/2051-1426-3-s2-p409 - 发表时间:
2015-11-04 - 期刊:
- 影响因子:10.600
- 作者:
Chang Liu;Maria Chikina;Creg J Workman;Dario AA Vignali - 通讯作者:
Dario AA Vignali
Elucidating the role of Neuropilin-1 in intra-tumoral regulatory T cell stability
- DOI:
10.1186/2051-1426-3-s2-p274 - 发表时间:
2015-11-04 - 期刊:
- 影响因子:10.600
- 作者:
Abigail E Overacre;Maria Chikina;Greg M Delgoffe;Dario AA Vignali - 通讯作者:
Dario AA Vignali
Antigen presentation by tumor infiltrating B cells influences CD4 T cell phenotype and function in primary lung cancer patient tumors
- DOI:
10.1186/2051-1426-3-s2-p397 - 发表时间:
2015-11-04 - 期刊:
- 影响因子:10.600
- 作者:
Tullia Bruno;Peggy Ebner;Brandon Moore;Daniel Munson;John Mitchell;Jeffrey Kern;Dario AA Vignali;Jill Slansky - 通讯作者:
Jill Slansky
Dario AA Vignali的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dario AA Vignali', 18)}}的其他基金
Regulatory T cells and the tumor microenvironment
调节性T细胞和肿瘤微环境
- 批准号:
10454307 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
项目1:评估LAG3和PD-1在黑色素瘤患者中的协同作用
- 批准号:
10683756 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
项目 1:评估 LAG3 和 PD-1 在黑色素瘤患者中的协同作用
- 批准号:
10469635 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Regulatory T cells and the tumor microenvironment
调节性T细胞和肿瘤微环境
- 批准号:
10298246 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Regulatory T cells and the tumor microenvironment
调节性T细胞和肿瘤微环境
- 批准号:
10670939 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Project 1: Evaluating the synergy of LAG3 and PD-1 in melanoma patients
项目 1:评估 LAG3 和 PD-1 在黑色素瘤患者中的协同作用
- 批准号:
10270231 - 财政年份:2021
- 资助金额:
$ 17.39万 - 项目类别:
Interleukin-35 and the tumor microenvironment
Interleukin-35 与肿瘤微环境
- 批准号:
9306799 - 财政年份:2016
- 资助金额:
$ 17.39万 - 项目类别:
Project 2 - Modulation of Anti-Tumor Immunity by Inhibitory Receptors
项目2——抑制性受体调节抗肿瘤免疫
- 批准号:
10670296 - 财政年份:2015
- 资助金额:
$ 17.39万 - 项目类别:
Synergies among inhibitory receptors in tolerance, cancer & antiviral immunity
抑制性受体在耐受性、癌症方面的协同作用
- 批准号:
10470821 - 财政年份:2015
- 资助金额:
$ 17.39万 - 项目类别:
相似海外基金
Thymus antibody-secreting cells: major players in autoimmunity.
胸腺抗体分泌细胞:自身免疫的主要参与者。
- 批准号:
502578 - 财政年份:2024
- 资助金额:
$ 17.39万 - 项目类别:
B cell development, autoimmunity and immune regulation
B 细胞发育、自身免疫和免疫调节
- 批准号:
MR/Y033701/1 - 财政年份:2024
- 资助金额:
$ 17.39万 - 项目类别:
Research Grant
Applying advanced understanding of CTLA-4 function to optimise therapies for autoimmunity
应用对 CTLA-4 功能的深入理解来优化自身免疫疗法
- 批准号:
MR/Y001273/1 - 财政年份:2024
- 资助金额:
$ 17.39万 - 项目类别:
Research Grant
MUC16 (CA125) mutations promote fibrosis and autoimmunity in systemic sclerosis
MUC16 (CA125) 突变促进系统性硬化症的纤维化和自身免疫
- 批准号:
478933 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Operating Grants
Development of serologic test for early risk stratification of islet autoimmunity in genetically predisposed T1D individuals
开发用于遗传易感性 T1D 个体胰岛自身免疫早期风险分层的血清学检测
- 批准号:
10760885 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Mechanisms of New-Onset Autoimmunity/Longitudinal Immune Systems Analysis (MONA-LISA)
新发自身免疫/纵向免疫系统分析(MONA-LISA)的机制
- 批准号:
10655219 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Autoimmunity-Associated B Cells in Lupus Nephritis
狼疮性肾炎中自身免疫相关的 B 细胞
- 批准号:
10582053 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Heparan sulfate as a platform to boost regulatory T cell suppression of autoimmunity
硫酸乙酰肝素作为增强调节性 T 细胞抑制自身免疫的平台
- 批准号:
490663 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Operating Grants
The interplay of sex hormones and chromosomes dictates pathogenicity in progressive CNS autoimmunity.
性激素和染色体的相互作用决定了进行性中枢神经系统自身免疫的致病性。
- 批准号:
488982 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Operating Grants
Understanding autoimmunity: Why do B cells sometimes attack our tissues instead of protecting us from infections?
了解自身免疫:为什么 B 细胞有时会攻击我们的组织而不是保护我们免受感染?
- 批准号:
2889164 - 财政年份:2023
- 资助金额:
$ 17.39万 - 项目类别:
Studentship